Your browser doesn't support javascript.
loading
Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial - Prodige 31 REMINET: An FFCD study.
Lepage, Côme; Phelip, Jean-Marc; Lievre, Astrid; Le-Malicot, Karine; Dahan, Laetitia; Tougeron, David; Toumpanakis, Christos; Di-Fiore, Frédéric; Lombard-Bohas, Catherine; Borbath, Ivan; Coriat, Romain; Lecomte, Thierry; Guimbaud, Rosine; Petorin, Caroline; Legoux, Jean-Louis; Michel, Pierre; Scoazec, Jean-Yves; Smith, Denis; Walter, Thomas.
Afiliação
  • Lepage C; EPICAD INSERM UMR LNC 1231, University of Burgundy Franche Comté, Dijon, France; Department of HGE & Digestive Oncology, University Hospital Dijon, University of Burgundy, Dijon, France. Electronic address: come.lepage@u-bourgogne.fr.
  • Phelip JM; Department of HGE & Digestive Oncology, University Hospital St Etienne, France.
  • Lievre A; Department of Gastroenterology, Rennes University Hospital, Rennes 1 University, INSERM U1242 "Chemistry Oncogenesis Stress Signalling", Rennes, FFCD, France.
  • Le-Malicot K; EPICAD INSERM UMR LNC 1231, University of Burgundy Franche Comté, Dijon, France.
  • Dahan L; C.H.U. la Timone and Université de la Méditerranée, Marseille, France.
  • Tougeron D; Department of Hepato-gastroenterology, Poitiers University Hospital and Poitiers University, Poitiers, France.
  • Toumpanakis C; Centre for Gastroenterology, Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK.
  • Di-Fiore F; Normandie University, UNIROUEN, Inserm 1245, IRON Group, Hôpital Universitaire de Rouen, Centre Henri-Becquerel, Département d'oncolgie Médicale, Service d'hépato-gastroentérologie, 76000 Rouen, France.
  • Lombard-Bohas C; Cancer Institute, ENETS Centre of Excellence, Hospices Civils de Lyon, France.
  • Borbath I; Department of Gastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Coriat R; AP-HP, Université Paris Descartes, Faculté de Médecine, Hôpital Cochin, Gastroenterology and Endoscopy Unit, Sorbonne Paris Cité, 75014 Paris, France.
  • Lecomte T; Department of HGE & Digestive Oncology, University Hospital Tours, François-Rabelais University, Tours, France.
  • Guimbaud R; Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Petorin C; Digestive Surgery and Oncological Department, Hospital Estaing, Clermont-Ferrand, France.
  • Legoux JL; Department of Hepato-Gastroenterology, La Source Hospital, Orléans, France.
  • Michel P; Normandie University, UNIROUEN, Inserm 1245, IRON Group, Hôpital Universitaire de Rouen, Centre Henri-Becquerel, Département d'oncolgie Médicale, Service d'hépato-gastroentérologie, 76000 Rouen, France.
  • Scoazec JY; Department of Pathology, University Paris-Saclay, Gustave Roussy Cancer Center, Villejuif, France.
  • Smith D; Hôpital Haut Lévêque, Service d'hépato-gastroentérologie, Pessac, France.
  • Walter T; Cancer Institute, ENETS Centre of Excellence, Hospices Civils de Lyon, France.
Eur J Cancer ; 175: 31-40, 2022 11.
Article em En | MEDLINE | ID: mdl-36087395
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Peptídeos Cíclicos / Somatostatina / Tumores Neuroendócrinos Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Peptídeos Cíclicos / Somatostatina / Tumores Neuroendócrinos Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article